Prospects for developing an effective particle-mediated DNA vaccine against influenza.
about
GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primatesEfficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.Cutaneous immunization: an evolving paradigm in influenza vaccinesVector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.Nano-biolistics: a method of biolistic transfection of cells and tissues using a gene gun with novel nanometer-sized projectiles.Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.Clinical applications of DNA vaccines: current progress.Advances in Gene Delivery Systems.The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responsesA novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.DNA immunization.A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin.Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.Swine influenza vaccines: current status and future perspectives.DNA vaccines for targeting bacterial infections.Novel vaccine approaches for protection against intracellular pathogens.DNA-based influenza vaccines as immunoprophylactic agents toward universality.A microarray MEMS device for biolistic delivery of vaccine and drug powdersOral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection.Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome.Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.
P2860
Q28751705-0E3215D9-140D-431A-951C-C9BB157BF8BEQ30204348-F6BD3C08-95D1-42D7-8404-931A101E4AF6Q30358895-6DCA0419-38C9-4326-A33C-CE8906A7B3CFQ30372481-828C9F3F-20C2-4ECD-A729-0C5516819211Q30407081-F3B50548-5F4D-460B-AED6-9843AB65D374Q30415387-1A32DE61-1EA7-4630-9A1D-689022DD3B0CQ33929498-5C2F9284-A97D-4425-B477-66A3886A9071Q34148160-01824857-5AB1-4919-A27C-198AAB464EFFQ35452312-BCD58E3F-57B8-4C58-AA5A-FA0F759B2A7CQ35632772-0869009E-BB60-4A0D-B93A-8E8DBFBFCBDBQ36256348-5EB3585B-30C5-4735-9F88-DA9A932DF31FQ36979271-ABFD177B-0614-4374-9B30-07B76B96C904Q37576264-251A8B1A-5258-4DE4-ABB4-E413B44219DFQ37623985-E951A612-D0A6-470E-829D-9B946A5F3AFDQ37730793-BBD3D595-80DF-4751-B219-1065CA35A1ECQ37749889-BBB6125C-1F6B-4D46-8C09-1CC5590C78D8Q37771943-C1C8E5FD-0A40-41E7-B517-E4ABEBCC8908Q38194389-35C110FD-83E5-4762-960C-4CC066ECB447Q38670879-BD7C2289-AF3A-4D9C-8BC7-1B9532FBE972Q38993921-81F030FB-E9DB-4E43-9048-BCB486C6129AQ39079605-106FC4DB-1283-4B8A-BB7B-57BDE43EA852Q39678964-41FD6EA6-2C02-4780-A4D2-D9C98F80C86CQ47562002-24D5EBB2-4C6F-43E7-B748-65DCA0A44FB8
P2860
Prospects for developing an effective particle-mediated DNA vaccine against influenza.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prospects for developing an effective particle-mediated DNA vaccine against influenza.
@ast
Prospects for developing an effective particle-mediated DNA vaccine against influenza.
@en
type
label
Prospects for developing an effective particle-mediated DNA vaccine against influenza.
@ast
Prospects for developing an effective particle-mediated DNA vaccine against influenza.
@en
prefLabel
Prospects for developing an effective particle-mediated DNA vaccine against influenza.
@ast
Prospects for developing an effective particle-mediated DNA vaccine against influenza.
@en
P2860
P356
P1476
Prospects for developing an effective particle-mediated DNA vaccine against influenza
@en
P2093
Hansi J Dean
P2860
P304
P356
10.1586/ERV.09.82
P577
2009-09-01T00:00:00Z